HANFORD GC
GenericsHANFORD GC is a generic drug manufacturer focused on Infectious Disease, Gastroenterology.
HANFORD GC's Key Drugs
HANFORD GC's key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).
HANFORD GC's Recent FDA Approvals
New NDA/BLA approvals for HANFORD GC over the last two years — novel drugs only, excluding generics and label supplements.
HANFORD GC's Therapeutic Areas
HANFORD GC's approved drugs and pipeline span 2 therapeutic areas, led by Infectious Disease and Gastroenterology. Weighted by commercial stage — approved drugs count most, then late-stage trials.
HANFORD GC's Top Competitors
HANFORD GC's closest competitors by therapeutic-area and drug-target overlap include Johnson & Johnson, Bristol-Myers Squibb, and APOTHECON. Ranked by overlap in therapeutic areas and drug targets across approved drugs and pipeline.
HANFORD GC Pipeline Snapshot
Active clinical trials for HANFORD GC across all therapeutic areas, from ClinicalTrials.gov.
Pro Intelligence Preview
Deep insights for investors and analysts
Revenue Insights
- • Top drug revenue breakdown
- • Drug-level revenue analysis
Trial Catalysts
- • Infectious Disease pipeline focus
- • Phase 3 readout tracking
Patent Risk
- • Patent expiration timeline
- • Revenue at risk analysis
Compare Companies
- • Side-by-side pipeline analysis
- • Revenue & market share comparison
Revenue forecasts • Trial milestones • Patent risk modeling
Active (0)
Discontinued (0)
Company Info
- First Approval
- 1993-04-15
- Latest
- 2013-05-31
- Applications
- 1